Johnson & Johnson Receives Subpoenas On Marketing Of Risperdal, Topamax and Natrecor
This article was originally published in The Pink Sheet Daily
Executive Summary
Subpoenas relate to investigations into sales and marketing practices by U.S. Attorneys in Philadelphia, Boston and San Francisco.